www.scorpiontx.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $420.47MM
Scorpion Therapeutics is an oncology company focused on transforming cancer treatment through an approach that offers precise selectivity and efficacy for oncology patients. Scorpion Therapeutics was founded in 2020 and is headquartered in Boston, MA. The company uses its proprietary technology platform that integrates cancer biology, medicinal chemistry, and data sciences for a holistic approach. The platform aims to allow Scorpion Therapeutics to create highly selective small-molecule compounds that target a broad spectrum of cancer drivers.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Scorpion Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.